Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.

van Royen, Niels

Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. [electronic resource] - Vascular medicine (London, England) 2003 - 191-6 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

1358-863X

10.1191/1358863x03vm496oa doi


Arterial Occlusive Diseases--drug therapy
Arteries--drug effects
Blood Flow Velocity--drug effects
Collateral Circulation--drug effects
Double-Blind Method
Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage
Humans
Injections, Subcutaneous
Intermittent Claudication--drug therapy
Neovascularization, Physiologic--drug effects
Research Design